Improved Muscle Function in Duchenne Muscular Dystrophy through L-Arginine and Metformin: An Investigator-Initiated, Open-Label, Single-Center, Proof-Of-Concept-Study.
Altered neuronal nitric oxide synthase function in Duchenne muscular dystrophy leads to impaired mitochondrial function which is thought to be one cause of muscle damage in this disease. The study tested if increased intramuscular nitric oxide concentration can improve mitochondrial energy metabolis...
Main Authors: | Patricia Hafner, Ulrike Bonati, Beat Erne, Maurice Schmid, Daniela Rubino, Urs Pohlman, Thomas Peters, Erich Rutz, Stephan Frank, Cornelia Neuhaus, Stefanie Deuster, Monika Gloor, Oliver Bieri, Arne Fischmann, Michael Sinnreich, Nuri Gueven, Dirk Fischer |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4723144?pdf=render |
Similar Items
-
Effect of combination l-citrulline and metformin treatment on motor function in patients with duchenne muscular dystrophy: a randomized clinical trial
by: Hafner, P, et al.
Published: (2019) -
Targeting Nrf2 for the treatment of Duchenne Muscular Dystrophy
by: Stephanie Kourakis, et al.
Published: (2021-01-01) -
Standard of care versus new-wave corticosteroids in the treatment of Duchenne muscular dystrophy: Can we do better?
by: Stephanie Kourakis, et al.
Published: (2021-03-01) -
Tamoxifen in Duchenne muscular dystrophy (TAMDMD): study protocol for a multicenter, randomized, placebo-controlled, double-blind phase 3 trial
by: Sara Nagy, et al.
Published: (2019-11-01) -
Serum Transaminase in Duchenne Dystrophy
by: J Gordon Millichap
Published: (2011-03-01)